*EH1182.2*
Reprinted
February 20, 2024
ENGROSSED
HOUSE BILL No. 1182
_____
DIGEST OF HB 1182 (Updated February 19, 2024 2:44 pm - DI 106)
Citations Affected: IC 4-22; IC 25-26; IC 35-48.
Synopsis: Regulation of controlled substances. Relocates requirements
that the board of pharmacy must comply with when adopting interim
rules declaring a substance a synthetic drug from the professional
licensing law to the statutes governing administrative rulemaking.
Makes certain changes to the lists of controlled substances.
Effective: Upon passage; July 1, 2024.
McNamara, Steuerwald
(SENATE SPONSOR — GLICK)
January 9, 2024, read first time and referred to Committee on Courts and Criminal Code.
January 18, 2024, reported — Do Pass.
January 22, 2024, read second time, ordered engrossed. Engrossed.
January 23, 2024, read third time, passed. Yeas 95, nays 0.
SENATE ACTION
February 5, 2024, read first time and referred to Committee on Corrections and Criminal
Law.
February 15, 2024, amended, reported favorably — Do Pass.
February 19, 2024, read second time, amended, ordered engrossed.
EH 1182—LS 6758/DI 92 Reprinted
February 20, 2024
Second Regular Session of the 123rd General Assembly (2024)
PRINTING CODE. Amendments: Whenever an existing statute (or a section of the Indiana
Constitution) is being amended, the text of the existing provision will appear in this style type,
additions will appear in this style type, and deletions will appear in this style type.
Additions: Whenever a new statutory provision is being enacted (or a new constitutional
provision adopted), the text of the new provision will appear in this style type. Also, the
word NEW will appear in that style type in the introductory clause of each SECTION that adds
a new provision to the Indiana Code or the Indiana Constitution.
Conflict reconciliation: Text in a statute in this style type or this style type reconciles conflicts
between statutes enacted by the 2023 Regular Session of the General Assembly.
ENGROSSED
HOUSE BILL No. 1182
A BILL FOR AN ACT to amend the Indiana Code concerning
criminal law and procedure.
Be it enacted by the General Assembly of the State of Indiana:
1 SECTION 1. IC 4-22-2.3-8, AS ADDED BY P.L.249-2023,
2 SECTION 43, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
3 UPON PASSAGE]: Sec. 8. (a) The Indiana board of pharmacy, on its
4 own initiative or under a written request from the state police
5 department, the United States Drug Enforcement Administration,
6 or a poison control center, may adopt interim rules under
7 IC 4-22-2-37.2 to declare a substance is a synthetic drug if the board
8 finds that the substance:
9 (1) has been scheduled or emergency scheduled by the United
10 States Drug Enforcement Administration;
11 (2) has been scheduled, emergency scheduled, or criminalized by
12 another state; or
13 (3) has:
14 (A) a high potential for abuse; and
15 (B) no accepted medical use in treatment in the United States
16 or lacks accepted safety for use in treatment under medical
17 supervision.
EH 1182—LS 6758/DI 92 2
1 (b) In making a determination under subsection (a)(3), the Indiana
2 board of pharmacy shall consider the following factors described in
3 IC 25-26-13-4.1. relating to the substance:
4 (1) The actual or relative potential for abuse.
5 (2) Scientific evidence of the substance's pharmacological
6 effect, if known.
7 (3) The state of scientific knowledge regarding the substance.
8 (4) The history and current pattern of abuse of the substance.
9 (5) The scope, duration, and significance of abuse of the
10 substance.
11 (6) The degree of risk to the public health.
12 (7) The psychic or psychological dependence liability of the
13 substance.
14 (c) Notwithstanding IC 4-22-2-37.2(i), a rule described in this
15 section becomes effective when the rule is published in the Indiana
16 Register. A rule described in this section expires not later than one (1)
17 year after June 30 of the year following the year in which the rule is
18 accepted for filing by the publisher of the Indiana Register and may not
19 be continued in another interim rule.
20 SECTION 2. IC 25-26-13-4.1, AS AMENDED BY P.L.196-2013,
21 SECTION 11, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
22 UPON PASSAGE]: Sec. 4.1. (a) The board may adopt an emergency
23 interim rule to declare that a substance is a synthetic drug in
24 accordance with the requirements of IC 4-22-2.3-8.
25 (b) The board may, on its own initiative or under a written request
26 from the state police department, the United States Drug Enforcement
27 Administration, or a poison control center, adopt an emergency rule
28 declaring a substance to be a synthetic drug if the board finds that the
29 substance:
30 (1) has been scheduled or emergency scheduled by the United
31 States Drug Enforcement Administration;
32 (2) has been scheduled, emergency scheduled, or criminalized by
33 another state; or
34 (3) has:
35 (A) a high potential for abuse; and
36 (B) no accepted medical use in treatment in the United States
37 or lacks accepted safety for use in treatment under medical
38 supervision.
39 (c) In making its determination under subsection (b)(3), the board
40 shall consider the following factors relating to the substance:
41 (1) The actual or relative potential for abuse.
42 (2) Scientific evidence of the substance's pharmacological effect,
EH 1182—LS 6758/DI 92 3
1 if known.
2 (3) The state of current scientific knowledge regarding the
3 substance.
4 (4) The history and current pattern of abuse of the substance.
5 (5) The scope, duration, and significance of abuse of the
6 substance.
7 (6) The degree of risk to the public health.
8 (7) The psychic or psychological dependence liability of the
9 substance.
10 (d) A rule adopted under this section becomes effective thirty (30)
11 days after it is filed with the publisher under IC 4-22-2-37.1.
12 (e) A rule adopted under this section expires on June 30 of the year
13 following the year in which it is filed with the publisher under
14 IC 4-22-2-37.1.
15 (f) The board may readopt under this section an emergency rule that
16 has expired.
17 SECTION 3. IC 35-48-2-4, AS AMENDED BY P.L.48-2023,
18 SECTION 4, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
19 JULY 1, 2024]: Sec. 4. (a) The controlled substances listed in this
20 section are included in schedule I.
21 (b) Opiates. Any of the following opiates, including their isomers,
22 esters, ethers, salts, and salts of isomers, esters, and ethers, unless
23 specifically excepted by rule of the board or unless listed in another
24 schedule, whenever the existence of these isomers, esters, ethers, and
25 salts is possible within the specific chemical designation:
26 4-fluoroisobutyryl fentanyl
27 Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-
28 piperidinyl]-N-phenylacetamide) (9815)
29 Acetyl fentanyl (Other names include:
30 N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide)
31 Acetylmethadol (9601)
32 Acrylfentanyl. Other name: N-(1-phenethylpiperidin-4-yl)-
33 N-phenylacrylamide
34 Allylprodine (9602)
35 Alpha-methylthiofentanyl (N-[1-methyl-2-(2-
36 thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide) (9832)
37 Alphacetylmethadol (9603)
38 Alphameprodine (9604)
39 Alphamethadol (9605)
40 Alpha'-Methyl butyryl fentanyl (2-methyl-N-(1-
41 phenethylpiperidin- 4-yl)-N-phenylbutanamide) (9864)
42 Alphamethylfentanyl (9814)
EH 1182—LS 6758/DI 92 4
1 Benzethidine (9606)
2 Beta-hydroxy-3-methylfentanyl (9831). Other name:
3 N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl
4 ]-N-phenylpropanamide
5 Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-
6 phenethyl)-4-piperidinyl]-N-phenylpropanamide) (9830)
7 Betacetylmethadol (9607)
8 Betameprodine (9608)
9 Betamethadol (9609)
10 Betaprodine (9611)
11 Brorphine(9098). Other name:
12 1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-1,3-dihydro-2
13 H-benzo[d]imidazol-2-one
14 2-(2-(4-butoxybenzyl)-5-nitro-1H-benzimidazol-1yl)-N,N-dieth
15 ylethan-1-amine (butonitazene); other name: butoxynitazene
16 Clonitazene (9612)
17 Cyclopentyl fentanyl. Other name:
18 N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide
19 Dextromoramide (9613)
20 Diampromide (9615)
21 Diethylthiambutene (9616)
22 N,N-diethyl-2-(2-(4-flourobenzyl)-5-nitro-1H-benzimidazol-1-y
23 l)ethan-1-amine (flunitazene)
24 N,N-diethyl-2-(2-(4-methoxybenzyl)-1H-benzimidazol-1-yl)eth
25 an-1-amine (metodesnitazene)
26 N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1H-benzimidazol-
27 1-yl)ethan-1-amine (metonitazene)
28 N,N-diethyl-2-(5-nitro-2-(4-propoxybenzyl)-1H-benzimidazol-
29 1-yl)ethan-1-amine (protonitazene); other name: pronitazene
30 Difenoxin (9168)
31 Dimenoxadol (9617)
32 Dimepheptanol (9618)
33 2',5'-Dimethoxyfentanyl (N-(1- (2,5-dimethoxyphenethyl)
34 piperidin-4-yl)- N-phenylpropionamide) (9861)
35 Dimethylthiambutene (9619)
36 Dioxaphetyl butyrate (9621)
37 Dipipanone (9622)
38 2-(2-(4-ethoxybenzyl)-1H-benzimidazol-1yl)-N,N-diethylethan-
39 1-amine (etodesnitazene; etazene)
40 2-(4-ethnoxybenzyl)5-nitro-1(2-(pyrorolidin-1-yl)ethyl)-1H-ben
41 zimidazol (N-pyrrolidino etonizatene; etonitazepyne)
42 Ethylmethylthiambutene (9623)
EH 1182—LS 6758/DI 92 5
1 Etonitazene (9624)
2 Etoxeridine (9625)
3 Fentanyl related substances.
4 Furanyl fentanyl (N-(1-phenethylpiperidin- 4-yl)-
5 N-phenylfuran- 2-carboxamide) (9834)
6 3-Furanyl fentanyl (N-(1-phenethylpiperidin- 4-yl)-
7 N-phenylfuran- 3- carboxamide) (9860)
8 Furethidine (9626)
9 Hydroxypethidine (9627)
10 Isobutyryl fentanyl. Other name:
11 N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide
12 Isotonitazene. Other name: N,N-diethyl-2-
13 (2-(4 isopropoxybenzyl)-5-nitro-1H-benzimidazol-
14 1-yl)ethan-1-amine)
15 Isovaleryl fentanyl (3-methyl- N-(1-phenethylpiperidin-4-yl)-
16 N- phenylbutanamide) (9862)
17 Ketobemidone (9628)
18 Levomoramide (9629)
19 Levophenacylmorphan (9631)
20 Meta-Fluorofentanyl (N-(3- fluorophenyl)- N-
21 (1-phenethylpiperidin-4-yl) propionamide) (9857)
22 Meta-Fluoroisobutyryl fentanyl (N-(3-fluorophenyl)- N-
23 (1-phenethylpiperidin-4-yl) isobutyramide) (9858)
24 Methoxyacetyl fentanyl. Other name:
25 2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide
26 3-Methylfentanyl [N-[3-methyl-1-(2-phenylethyl)-4-
27 piperidyl]-N-phenyl-propanimide](9813)
28 3-Methylthiofentanyl (N-[(3-methyl-1-(2-thienyl)ethyl-4-
29 piperidinyl]-N-phenylpropanamide) (9833)
30 M etonitazene
31 (N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1H-benzimida
32 zol-1-yl)ethan-1-amine) (9757)
33 MPPP (1-methyl-4-phenyl-4-propionoxypiperidine) (9961)
34 Morpheridine (9632)
35 N-[1-benzyl-4-piperidyl]-N-phenylpropanamide (benzylfentanyl),
36 including any isomers, salts, or salts of isomers (9818)
37 N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl] 25 piperidin-4-yl]-
38 N-phenylpropionamide, also known as N-[1-[2-hydroxy-2-
39 (2-thienyl)ethyl] -4- piperidinyl]- N-phenylpropanamide,
40 (beta-hydroxythiofentanyl)
41 N-(4-chlorophenyl)- N-(1-phenethylpiperidin-4-yl) isobutyramide
42 (para-chloroisobutyryl fentanyl)
EH 1182—LS 6758/DI 92 6
1 N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)
2 acetamide (ocfentanil)
3 N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4 -yl) butyramide
4 (para-fluorobutyryl fentanyl)
5 N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide, also known
6 as N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide, (butyryl
7 fentanyl)
8 N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide (valeryl
9 fentanyl)
10 N-(4-methoxyphenyl)-N-(1-phenethylpiperidin -4-yl) butyramide
11 (para-methoxybutyryl fentanyl)
12 N-[1-(2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide
13 (thenylfentanyl), including any isomers, salts, or salts of isomers
14 (9834)
15 N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide (isobutyryl
16 fentanyl)
17 N-(1-phenethylpiperidin-4-yl)- Nphenylcyclopentanecarboxamide
18 (cyclopentyl fentanyl)
19 Noracymethadol (9633)
20 Norlevorphanol (9634)
21 Normethadone (9635)
22 Norpipanone (9636)
23 Ocfentanil. Other name:
24 N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)
25 acetamide
26 Ortho-fluorofentanyl or 2-fluorofentanyl. Other name:
27 N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide
28 Ortho-Fluorofuranyl fentanyl (N-(2-fluorophenyl)- N-
29 (1-phenethylpiperidin-4-yl)furan-2-carboxamide) (9863)
30 Para-chloroisobutyryl fentanyl. Other name:
31 N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide
32 Para-fluorobutyryl fentanyl. Other name:
33 N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide
34 Para-fluorofentanyl (N-(4-fluorophenyl)-N-
35 [1-(2-phenethyl)-4-piperidinyl] propanamide (9812)
36 Para-methoxybutyryl fentanyl. Other name:
37 N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)butyramide
38 Para-Methoxyfuranyl fentanyl (N-(4-methoxyphenyl)- N-
39 (1-phenethylpiperidin-4-yl) furan-2-carboxamide (9859)
40 Para-Methylcyclopropyl fentanyl (N-(4-methylphenyl)- N-
41 (1-phenethylpiperidin- 4-yl)cyclopropanecarboxamide) (9865)
42 Phenadoxone (9637)
EH 1182—LS 6758/DI 92 7
1 Phenampromide (9638)
2 Phenomorphan (9647)
3 Phenoperidine (9641)
4 PEPAP [1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine] (9663)
5 Piritramide (9642)
6 Proheptazine (9643)
7 Properidine (9644)
8 Propiram (9649)
9 Racemoramide (9645)
10 Tetrahydrofuranyl fentanyl. Other name:
11 N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carb
12 oxamide
13 Thiofentanyl (N-phenyl-N-[ 1-(2-thienyl)ethyl-4-
14 piperidinyl]-propanamide) (9835)
15 Tianeptine (7-[(3-chloro-6-methyl-5,5-dioxo-11H-benzo[c]
16 [2,1]benzothiazepin-11-yl)amino]heptanoic acid)
17 Tilidine (9750)
18 Trimeperidine (9646)
19 U47700 (3,4-dichloro- N- [2-dimethylamino)cyclohexyl]-
20 N-methyl- benzamide)
21 Valeryl fentanyl. Other name:
22 N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide
23 Zipeprol (1-methoxy-3- [4-(2-methoxy-2-phenylethyl) piperazin-
24 1-yl]- 1- phenylpropan- 2-ol) (9873)
25 (c) Opium derivatives. Any of the following opium derivatives, their
26 salts, isomers, and salts of isomers, unless specifically excepted by rule
27 of the board or unless listed in another schedule, whenever the
28 existence of these salts, isomers, and salts of isomers is possible within
29 the specific chemical designation:
30 Acetorphine (9319)
31 Acetyldihydrocodeine (9051)
32 Benzylmorphine (9052)
33 Codeine methylbromide (9070)
34 Codeine-N-Oxide (9053)
35 Cyprenorphine (9054)
36 Desomorphine (9055)
37 Dihydromorphine (9145)
38 Drotebanol (9335)
39 Etorphine (except hydrochloride salt) (9056)
40 Heroin (9200)
41 Hydromorphinol (9301)
42 Methyldesorphine (9302)
EH 1182—LS 6758/DI 92 8
1 Methyldihydromorphine (9304)
2 Morphine methylbromide (9305)
3 Morphine methylsulfonate (9306)
4 Morphine-N-Oxide (9307)
5 Myrophine (9308)
6 Nicocodeine (9309)
7 Nicomorphine (9312)
8 Normorphine (9313)
9 Pholcodine (9314)
10 Thebacon (9315)
11 (d) Hallucinogenic substances. Unless specifically excepted or
12 unless listed in another schedule, any material, compound, mixture, or
13 preparation which contains any quantity of the following
14 hallucinogenic, psychedelic, or psychogenic substances, their salts,
15 isomers, and salts of isomers whenever the existence of these salts,
16 isomers, and salts of isomers is possible within the specific chemical
17 designation (for purposes of this subsection only, the term "isomer"
18 includes the optical, position, and geometric isomers):
19 (1) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine (7473). Other name:
20 TCPy.
21 (2) 4-Bromo-2, 5-Dimethoxyamphetamine (7391). Some trade or
22 other names: 4-Bromo-2, 5-Dimethoxy-a-methylphenethylamine;
23 4-Bromo-2, 5-DMA.
24 (3) 4-Bromo-2, 5-dimethoxyphenethylamine (7392). Some trade
25 or other names:
26 2-[4-bromo-2,5-dimethoxyphenyl]-1-aminoethane;
27 alpha-desmethyl DOB; 2C-B, Nexus.
28 (4) 2, 5-Dimethoxy-4-ethylamphet-amine (7399). Other name:
29 DOET.
30 (5) 2, 5-Dimethoxy-4-(n)-propylthiophenethylamine (7348).
31 Other name: 2C-T-7.
32 (6) 2, 5-Dimethoxyamphetamine (7396). Some trade or other
33 names: 2, 5-Dimethoxy-a-methylphenethylamine; 2, 5-DMA.
34 (7) 4-Methoxyamphetamine (7411). Some trade or other names:
35 4-Methoxy-a-methylphenethylamine; Paramethoxyamphetamine;
36 PMA.
37 (8) 5-Methoxy-3, 4-methylenedioxy amphetamine (7401). Other
38 Name: MMDA.
39 (9) 5-Methoxy-N, N-diisopropyltryptamine, including any
40 isomers, salts, or salts of isomers (7439). Other name:
41 5-MeO-DIPT.
42 (10) 4-methyl-2, 5-dimethoxyamphetamine (7395). Some trade
EH 1182—LS 6758/DI 92 9
1 and other names: 4-methyl-2,
2 5-dimethoxy-a-methylphenethylamine; DOM; and STP.
3 (11) 3, 4-methylenedioxy amphetamine (7400). Other name:
4 MDA.
5 (12) 3,4-methylenedioxy-N-ethylamphetamine (7404). Other
6 names: N-ethyl-alpha-methyl-3,4(methylenedioxy)
7 phenethylamine; N-ethyl MDA; MDE; and MDEA.
8 (13) 3, 4-methylenedioxymethamphetamine (MDMA) (7405).
9 (14) 3, 4, 5-trimethoxy amphetamine (7390). Other name: TMA.
10 (15) Alpha-ethyltryptamine (7249). Some trade and other names:
11 Etryptamine; Monase; [alpha]-ethyl-1H-indole-3-ethanamine;
12 3-(2-aminobutyl) indole; [alpha]-ET; and AET.
13 (16) Alpha-methyltryptamine (7432). Other name: AMT.
14 (17) Bufotenine (7433). Some trade and other names:
15 3-(B-Dimethylaminoethyl)-5-hydroxyindole;
16 3-(2-dimethylaminonethyl)-5-indolol; N, N-dimethylserotonin;
17 5-hydroxy-N, N-dimethyltryptamine; mappine.
18 (18) Diethyltryptamine (7434). Some trade or other names: N,
19 N-Diethyltryptamine; DET.
20 (19) Dimethyltryptamine (7435). Some trade or other names:
21 DMT.
22 (20) Ibogaine (7260). Some trade and other names: 7-Ethyl-6, 6b,
23 7, 8, 9, 10, 12, 13-octahydro-2-methoxy-6, 9-methano-5H-pyrido
24 (1', 2': 1, 2, azepino 4, 5-b) indole; tabernanthe iboga.
25 (21) Lysergic acid diethylamide (7315). Other name: LSD.
26 (22) Marijuana (7360).
27 (23) Mescaline (7381).
28 (24) Methoxetamine[2-(ethylamino)-2-(3-methoxyphenyl)
29 cyclohexan-1-one or 2-(3-methoxyphenyl)-2-(ethylamino)-
30 cyclohexanone].
31 (25) Parahexyl (7374). Some trade or other names:
32 3-Hexyl-1-hydroxy-7, 8, 9, 10-Tetrahydro-6, 6,
33 9-trimethyl-6H-dibenzo (b,d) pyran; Snyhexyl.
34 (26) Peyote (7415), including:
35 (A) all parts of the plant that are classified botanically as
36 lophophora williamsii lemaire, whether growing or not;
37 (B) the seeds thereof;
38 (C) any extract from any part of the plant; and
39 (D) every compound, manufacture, salt, derivative, mixture, or
40 preparation of the plant, its seeds, or extracts.
41 (27) N-ethyl-3-piperidyl benzilate (7482). Other name: DMZ.
42 (28) N-hydroxy-3,4-methylenedioxyamphetamine (7402). Other
EH 1182—LS 6758/DI 92 10
1 names: N-hydroxy-alpha-methyl-3,4
2 (methylenedioxy)phenethylamine; and N-hydroxy MDA.
3 (29) N-methyl-3-piperidyl benzilate (7484). Other name: LBJ.
4 (30) Psilocybin (7437).
5 (31) Psilocyn (7438).
6 (32) Tetrahydrocannabinols (7370), including synthetic
7 equivalents of the substances contained in the plant, or in the
8 resinous extractives of Cannabis, sp. and synthetic substances,
9 derivatives, and their isomers with similar chemical structure and
10 pharmacological activity such as:
11 (A) ð
1
cis or trans tetrahydrocannabinol, and their optical
12 isomers;
13 (B) ð
6
cis or trans tetrahydrocannabinol, and their optical
14 isomers; and
15 (C) ð
3,
4 cis or trans tetrahydrocannabinol, and their optical
16 isomers.
17 Since nomenclature of these substances is not internationally
18 standardized, compounds of these structures, regardless of
19 numerical designation of atomic positions are covered. Other
20 name: THC.
21 (33) Ethylamine analog of phencyclidine (7455). Some trade or
22 other names: N-Ethyl-1-phenylcyclohexylamine;
23 (1-phenylcyclohexyl) ethylamine; N-(1-phenylcyclohexyl)
24 ethylamine; cyclohexamine; PCE.
25 (34) Pyrrolidine analog of phencyclidine (7458). Some trade or
26 other names: 1-(1-phenylcyclohexyl)-pyrrolidine; PCP
y; PHP.
27 (35) Thiophene analog of phencyclidine (7470). Some trade or
28 other names: 1-(1-(2-thienyl) cyclohexyl) piperidine; 2-Thienyl
29 Analog of Phencyclidine; TPCP.
30 (36) Salvia divinorum or salvinorin A, including:
31 (A) all parts of the plant that are classified botanically as salvia
32 divinorum, whether growing or not;
33 (B) the seeds of the plant;
34 (C) any extract from any part of the plant; and
35 (D) every compound, manufacture, salt, derivative, mixture, or
36 preparation of the plant, its seeds, or extracts.
37 (37) 5-Methoxy-N,N-Dimethyltryptamine. Some trade or other
38 names: 5-methoxy-3-[2- (dimethylamino)ethyl]indole;
39 5-MeO-DMT.
40 (38) 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E).
41 (39) 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D).
42 (40) 2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C-C).
EH 1182—LS 6758/DI 92 11
1 (41) 2-(4-Iodo-2,5-dimethoxyphenyl) ethanamine (2C-I).
2 (42) 2-[4-(Ethylthio)-2,5-dimethoxyphenyl] ethanamine (2C-T-2).
3 (43) 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl] ethanamine
4 (2C-T-4).
5 (44) 2-(2,5-Dimethoxyphenyl) ethanamine (2C-H).
6 (45) 2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C-N).
7 (46) 2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2C-P).
8 (47) Deschloroketamine (2-Phenyl-2-
9 (methylamino)cyclohexanone).
10 (48) 4-Hydroxy-MET (4-Hydroxy-N-methyl-N-
11 ethyltryptamine).
12 (49) N-methyltryptamine (1H-Indole-3-ethanamine, N-methyl-).
13 (50) 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)butan-1-one
14 (other names: eutylone; bk-EBDB (7549)).
15 (51) N-(1-amino- 3,3-dimethyl-1- oxobutan-2-yl)-
16 1-butyl-1H-indazole-3- carboxamide (other name:
17 ADB–BUTINACA) (7027).
18 (52) 4-methyl-1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one (other
19 names: á-PiHP; alpha-PiHP) (7551).
20 (53) 2-(methylamino)-1-(3-methylphenyl)propan-1-one (other
21 names: 3–MMC; 3-methylmethcathinone) (1259).
22 (e) Depressants. Unless specifically excepted in a rule adopted by
23 the board or unless listed in another schedule, any material, compound,
24 mixture, or preparation which contains any quantity of the following
25 substances having a depressant effect on the central nervous system,
26 including its salts, isomers, and salts of isomers whenever the existence
27 of such salts, isomers, and salts of isomers is possible within the
28 specific chemical designation:
29 Etizolam (4-(2- chlorophenyl)-2- ethyl-9- methyl- 6H-
30 thieno[3,2-f] [1,2,4] triazolo[4,3-a] [1,4diazepine) (other names
31 include: Etilaam, Etizest, Depas, Etizola, Sedekopan, and
32 Pasaden)
33 Flubromazolam (8-bromo-6-(2-fluorophenyl)-1-methyl-
34 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine)
35 Gamma-hydroxybutyric acid (other names include GHB;
36 gamma-hydroxybutyrate; 4-hydroxybutanoic acid; sodium
37 oxybate; sodium oxybutyrate) (2010)
38 Mecloqualone (2572)
39 Methaqualone (2565)
40 (f) Stimulants. Unless specifically excepted or unless listed in
41 another schedule, any material, compound, mixture, or preparation that
42 contains any quantity of the following substances having a stimulant
EH 1182—LS 6758/DI 92 12
1 effect on the central nervous system, including its salts, isomers, and
2 salts of isomers:
3 ([+/-]) cis-4-methylaminorex (([+/-])cis-4,5-
4 dihydro-4-methyl-5-phenyl-2-oxazolamine) (1590).
5 Amineptine (7-[(10,11-dihydro-5H- dibenzo[a,d]cyclohepten- 5-
6 yl)amino] heptanoic acid) (1219).
7 Aminorex (1585). Other names: aminoxaphen;
8 2-amino-5-phenyl-2-oxazoline; or
9 4,5-dihydro-5-phenyl-2-oxazolamine.
10 4,4'-Dimethylaminorex (4,4'-DMAR; 4,5-dihydro- 4-methyl-5-(4-
11 methylphenyl)- 2- oxazolamine; 4-methyl-5- (4-methylphenyl)-
12 4,5-dihydro-1,3-oxazol- 2-amine).
13 Benzylone, 1-(1,3-benzodioxol-5-yl)-2-(benzylamino)propan
14 -1-one. Synonyms: BMDP, N-benzyl methylone,
15 3,4-Methylenedioxy-Nbenzylcathinone,
16 N-benzyl-3,4-methylenedioxycathinone.
17 Cathinone (1235). Some trade or other names:
18 2-amino-1-phenyl-1-propanone; alpha-aminopropiophenone;
19 2-aminopropiophenone; and norephedrone.
20 Fenethylline (1503).
21 N-Benzylpiperazine (7493). Other names: BZP; and
22 1-benzylpiperazine.
23 N-ethylamphetamine (1475).
24 Mesocarb (N-phenyl-N-(3-(1-
25 phenylpropan-2-yl)-1,2,3-oxadiazol-3- ium-5yl)carbamimidate)
26 (1227).
27 Methcathinone (1237). Some other trade names:
28 2-Methylamino-1-Phenylpropan-I-one; Ephedrone;
29 Monomethylpropion; UR 1431.
30 N, N-dimethylamphetamine (1480). Other names: N,
31 N-alpha-trimethyl-benzeneethanamine; and N,
32 N-alpha-trimethylphenethylamine.
33 Methiopropamine (N-methyl-1- (thiophen-2-yl) propan-2-
34 amine) (methiopropamine). (1478).
35 (g) Synthetic drugs as defined in IC 35-31.5-2-321.
36 SECTION 4. IC 35-48-2-6, AS AMENDED BY P.L.48-2023,
37 SECTION 5, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
38 JULY 1, 2024]: Sec. 6. (a) The controlled substances listed in this
39 section are included in schedule II.
40 (b) Any of the following substances, except those narcotic drugs
41 listed in other schedules, whether produced directly or indirectly by
42 extraction from substances of vegetable origin, or independently by
EH 1182—LS 6758/DI 92 13
1 means of chemical synthesis, or by combination of extraction and
2 chemical synthesis:
3 (1) Opium and opiate, and any salt, compound, derivative, or
4 preparation of opium or opiate, excluding apomorphine,
5 dextrorphan, nalbuphine, naloxone, naltrexone, and their
6 respective salts but including:
7 (A) raw opium (9600);
8 (B) opium extracts (9610);
9 (C) opium fluid extracts (9620);
10 (D) powdered opium (9639);
11 (E) granulated opium (9640);
12 (F) tincture of opium (9630);
13 (G) codeine (9050);
14 (H) dihydroetorphine (9334);
15 (I) ethylmorphine (9190);
16 (J) etorphine hydrochloride (9059);
17 (K) hydrocodone (9193), and any hydrocodone combination
18 product, as determined by the federal Food and Drug
19 Administration;
20 (L) hydromorphone (9150);
21 (M) metopon (9260);
22 (N) morphine (9300);
23 (O) oxycodone (9143);
24 (P) oxymorphone (9652);
25 (Q) thebaine (9333); and
26 (R) oripavine.
27 (2) Any salt, compound, isomer, derivative, or preparation thereof
28 which is chemically equivalent or identical with any of the
29 substances referred to in subdivision (b)(1) of this section, but not
30 including the isoquinoline alkaloids of opium.
31 (3) Opium poppy and poppy straw.
32 (4) Cocaine (9041). Coca leaves (9040) and any salt,
33 compound, derivative, or preparation of coca leaves
34 (including cocaine (9041) and ecgonine (8180) and their salts,
35 isomers, derivatives, and salts of isomers and derivatives), and
36 any salt, compound, derivative, or preparation thereof that is
37 chemically equivalent or identical with these substances
38 except that the substances do not include:
39 (A) decocainized coca leaves or an extraction of coca leaves
40 that does not contain cocaine or ecgonine;
41 (B) [
123
I]ioflupane; or
42 (C) [
18
F]FP-CIT.
EH 1182—LS 6758/DI 92 14
1 (5) Concentrate of poppy straw (the crude extract of poppy straw
2 in either liquid, solid, or powder form which contains the
3 phenanthrene alkaloids of the opium poppy) (9670).
4 (c) Opiates. Any of the following opiates, including their isomers,
5 esters, ethers, salts, and salts of isomers, esters, and ethers whenever
6 the existence of these isomers, esters, ethers, and salts is possible
7 within the specific chemical designation:
8 Alfentanil (9737)
9 Alphaprodine (9010)
10 Anileridine (9020)
11 Bezitramide (9800)
12 Bulk dextropropoxyphene (nondosage forms) (9273)
13 Carfentanil (9743)
14 Dihydrocodeine (9120)
15 Diphenoxylate (9170)
16 Fentanyl (9801)
17 Isomethadone (9226)
18 Levo-alphacetylmethadol (9648). Other names:
19 Levo-alpha-acetylmethadol; levomethadyl acetate; and LAAM.
20 Levomethorphan (9210)
21 Levorphanol (9220)
22 Metazocine (9240)
23 Methadone (9250)
24 Methadone-Intermediate, 4-cyano-2-dimethyl-amino-4,
25 4-diphenyl butane (9254)
26 Moramide-Intermediate, 2-methyl-3-morpholino-1,
27 1-diphenylpropane- carboxylic acid (9802)
28 Oliceridine (N-[(3-methoxythiophen- 2-yl) methyl]({2- [(9R)-9-
29 (pyridin- 2-yl)-6-oxaspiro[4.5]decan-9-yl]ethyl})amine) (9245)
30 Pethidine (Meperidine) (9230)
31 Pethidine-Intermediate- A, 4-cyano-1-methyl-4-phenylpiperidine
32 (9232)
33 Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate
34 (9233)
35 Pethidine-Intermediate-C,1-methyl-4-phenylpiperidine-4-carbo
36 xylic acid (9234)
37 Phenazocine (9715)
38 Piminodine (9730)
39 Racemethorphan (9732)
40 Racemorphan (9733)
41 Remifentanil (9739)
42 Sufentanil (9740)
EH 1182—LS 6758/DI 92 15
1 Tapentadol
2 Thiafentanil
3 (d) Stimulants. Any material compound, mixture, or preparation
4 which contains any quantity of the following substances having a
5 potential for abuse associated with a stimulant effect on the central
6 nervous system:
7 (1) Amphetamine, its salts, optical isomers, and salts of its optical
8 isomers (1100).
9 (2) Methamphetamine, including its salts, isomers, and salts of its
10 isomers (1105).
11 (3) Phenmetrazine and its salts (1631).
12 (4) Methylphenidate (1724).
13 (5) Lisdexamfetamine, its salts, its isomers, and salts of its
14 isomers.
15 (e) Depressants. Unless specifically excepted by rule of the board
16 or unless listed in another schedule, any material, compound, mixture,
17 or preparation which contains any quantity of the following substances
18 having a depressant effect on the central nervous system, including its
19 salts, isomers, and salts of isomers whenever the existence of such
20 salts, isomers, and salts of isomers is possible within the specific
21 chemical designation:
22 Amobarbital (2125)
23 Glutethimide (2550)
24 Pentobarbital (2270)
25 Phencyclidine (7471)
26 Secobarbital (2315)
27 (f) Immediate precursors. Unless specifically excepted by rule of the
28 board or unless listed in another schedule, any material, compound,
29 mixture, or preparation which contains any quantity of the following
30 substances:
31 (1) Immediate precursor to amphetamine and methamphetamine:
32 Phenylacetone (8501). Some trade or other names:
33 phenyl-2-propanone; P2P; benzyl methyl ketone; methyl benzyl
34 ketone.
35 (2) Immediate precursors to phencyclidine (PCP):
36 (A) 1-phenylcyclohexylamine (7460); or
37 (B) 1-piperidinocyclohexanecarbonitrile (PCC) (8603).
38 (3) Immediate precursor to fentanyl:
39 (A) 4-anilino-N-phenethylpiperidine (ANPP) (8333); or
40 (B) N-phenyl-N-(piperidin-4-yl)propionamide (norfentanyl)
41 (8366).
42 (g) Hallucinogenic substances:
EH 1182—LS 6758/DI 92 16
1 Dronabinol oral solution. Other name:
2 (-)-delta-9-trans-tetrahydrocannabinol (delta-9-THC).
3 Nabilone (7379). Other name: (+/-)-trans-3-
4 (1,1-dimethylheptyl)-6, 6a, 7, 8, 10, 10a-hexahydro-1-hydroxy -6,
5 6-dimethyl-9H-dibenzo [b,d] pyran-9-one.
6 SECTION 5. IC 35-48-2-10, AS AMENDED BY P.L.48-2023,
7 SECTION 6, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
8 JULY 1, 2024]: Sec. 10. (a) The controlled substances listed in this
9 section are included in schedule IV.
10 (b) Narcotic drugs. Unless specifically excepted in a rule adopted
11 by the board or unless listed in another schedule, any material,
12 compound, mixture, or preparation containing any of the following
13 narcotic drugs, or their salts calculated as the free anhydrous base or
14 alkaloid, in the following limited quantities:
15 (1) Not more than 1 milligram of difenoxin (9618) and not less
16 than 25 micrograms of atropine sulfate per dosage unit.
17 (2) Dextropropoxyphene (alpha- (+)-4-dimethylamino-1,2-
18 diphenyl-3-methyl-2-propionoxybutane (9278).
19 (c) Depressants. Unless specifically excepted in a rule adopted by
20 the board or unless listed in another schedule, any material, compound,
21 mixture, or preparation which contains any quantity of the following
22 substances, including its salts, isomers, and salts of isomers whenever
23 the existence of such salts, isomers, and salts of isomers is possible
24 within the specific chemical designation:
25 Alfaxalone (2731).
26 Alprazolam (2882).
27 Barbital (2145).
28 Brexanolone (2400).
29 Bromazepam (2748).
30 Camazepam (2749).
31 Carisoprodol.
32 Chloral betaine (2460).
33 Chloral hydrate (2465).
34 Chlordiazepoxide (2744).
35 Clobazam (2751).
36 Clonazepam (2737).
37 Clorazepate (2768).
38 Clotiazepam (2752).
39 Cloxazolam (2753).
40 Daridorexant (2410).
41 Delorazepam (2754).
42 Diazepam (2765).
EH 1182—LS 6758/DI 92 17
1 Dichloralphenazone (2467).
2 Estazolam (2756).
3 Ethchlorvynol (2540).
4 Ethinamate (2545).
5 Ethyl loflazepate (2758).
6 Fludiazepam (2759).
7 Flunitrazepam (2763).
8 Flurazepam (2767).
9 Fospropofol (2138).
10 Halazepam (2762).
11 Haloxazolam (2771).
12 Ketazolam (2772).
13 Lemborexant (2245).
14 Loprazolam (2773).
15 Lorazepam (2885).
16 Lormetazepam (2774).
17 Mebutamate (2800).
18 Medazepam (2836).
19 Meprobamate (2820).
20 Methohexital (2264).
21 Methylphenobarbital (mephobarbital) (2250).
22 Midazolam (2884).
23 Nimetazepam (2837).
24 Nitrazepam (2834).
25 Nordiazepam (2838).
26 Oxazepam (2835).
27 Oxazolam (2839).
28 Paraldehyde (2585).
29 Petrichloral (2591).
30 Phenobarbital (2285).
31 Pinazepam (2883).
32 Prazepam (2764).
33 Quazepam (2881).
34 Remimazolam (2846).
35 Suvorexant (2223).
36 Temazepam (2925).
37 Tetrazepam (2886).
38 Triazolam (2887).
39 Zaleplon (2781).
40 Zolpidem (Ambien) (2783).
41 Zopiclone (2784).
42 Zuranolone (2420).
EH 1182—LS 6758/DI 92 18
1 (d) Fenfluramine. Any material, compound, mixture, or preparation
2 which contains any quantity of the following substances, including its
3 salts, isomers (whether optical, position, or geometric), and salts of
4 such isomers, whenever the existence of such salts, isomers, and salts
5 of isomers is possible.
6 Fenfluramine (1670).
7 (e) (d) Stimulants. Unless specifically excepted in a rule adopted by
8 the board or unless listed in another schedule, any material, compound,
9 mixture, or preparation which contains any quantity of the following
10 substances having a stimulant effect on the central nervous system,
11 including its salts, isomers (whether optical, position, or geometric),
12 and salts of such isomers whenever the existence of such salts, isomers,
13 and salts of isomers is possible within the specific chemical
14 designation:
15 Cathine ((+)-norpseudoephedrine) (1230).
16 Diethylpropion (1610).
17 Fencamfamin (1760).
18 Fenproporex (1575).
19 Mazindol (1605).
20 Mefenorex (1580).
21 Modafinil (1680).
22 Pemoline (including organometallic complexes and chelates
23 thereof) (1530).
24 Phentermine (1640).
25 Pipradrol (1750).
26 Serdexmethylphenidate (1729).
27 Sibutramine (1675).
28 Solriamfetol (2-amino-3-phenylpropyl carbamate;
29 benzenepropanol, beta-amino-, carbamate (ester)) (1650).
30 SPA ((-)-1-dimethylamino-1,2-diphenylethane (1635).
31 (f) (e) Other substances. Unless specifically excepted or unless
32 listed in another schedule, any material, compound, mixture, or
33 preparation which contains any quantity of the following substances
34 including its salts:
35 Butorphanol (including its optical isomers) (9720).
36 Pentazocine (9709).
37 (g) (f) Tramadol (Ultram).
38 (h) (g) The board may except by rule any compound, mixture, or
39 preparation containing any depressant substance listed in subsection
40 (b), (c), (d), or (e), or (f) from the application of any part of this article
41 if the compound, mixture, or preparation contains one (1) or more
42 active medicinal ingredients not having a depressant effect on the
EH 1182—LS 6758/DI 92 19
1 central nervous system, and if the admixtures are included therein in
2 combinations, quantity, proportion, or concentration that vitiate the
3 potential for abuse of the substances which have a depressant effect on
4 the central nervous system.
5 SECTION 6. An emergency is declared for this act.
EH 1182—LS 6758/DI 92 20
COMMITTEE REPORT
Mr. Speaker: Your Committee on Courts and Criminal Code, to
which was referred House Bill 1182, has had the same under
consideration and begs leave to report the same back to the House with
the recommendation that said bill do pass.
(Reference is to HB 1182 as introduced.)
MCNAMARA
Committee Vote: Yeas 12, Nays 0
_____
COMMITTEE REPORT
Madam President: The Senate Committee on Corrections and
Criminal Law, to which was referred House Bill No. 1182, has had the
same under consideration and begs leave to report the same back to the
Senate with the recommendation that said bill be AMENDED as
follows:
Page 3, between lines 16 and 17, begin a new paragraph and insert:
"SECTION 3. IC 25-26-13-31.2, AS AMENDED BY P.L.56-2023,
SECTION 239, IS AMENDED TO READ AS FOLLOWS
[EFFECTIVE JULY 1, 2024]: Sec. 31.2. (a) A pharmacist may
administer an immunization to an individual under a drug order or
prescription.
(b) Subject to subsection (c), a pharmacist may administer
immunizations for the following an immunization that is
recommended by the federal Centers for Disease Control and
Prevention Advisory Committee on Immunization Practices to a
group of individuals under a drug order, under a prescription, or
according to a protocol approved by a physician.
(1) Influenza.
(2) Shingles (herpes zoster).
(3) Pneumonia.
(4) Tetanus, diphtheria, and acellular pertussis (whooping cough).
(5) Human papillomavirus (HPV) infection.
(6) Meningitis.
(7) Measles, mumps, and rubella.
(8) Varicella.
(9) Hepatitis A.
(10) Hepatitis B.
(11) Haemophilus influenzae type b (Hib).
EH 1182—LS 6758/DI 92 21
(12) Coronavirus disease.
(c) A pharmacist may administer an immunization under subsection
(b) if the following requirements are met:
(1) The physician specifies in the drug order, prescription, or
protocol the group of individuals to whom the immunization may
be administered.
(2) The physician who writes the drug order, prescription, or
protocol is licensed and actively practicing with a medical office
in Indiana and not employed by a pharmacy.
(3) The pharmacist who administers the immunization is
responsible for notifying, not later than fourteen (14) days after
the pharmacist administers the immunization, the physician who
authorized the immunization and the individual's primary care
physician that the individual received the immunization.
(4) If the physician uses a protocol, the protocol may apply only
to an individual or group of individuals who
(A) except as provided in clause (B), are at least eleven (11)
years of age. or
(B) for the pneumonia immunization under subsection (b)(3),
are at least fifty (50) years of age.
(5) Before administering an immunization to an individual
according to a protocol approved by a physician, the pharmacist
must receive the consent of one (1) of the following:
(A) If the individual to whom the immunization is to be
administered is at least eleven (11) years of age but less than
eighteen (18) years of age, the parent or legal guardian of the
individual.
(B) If the individual to whom the immunization is to be
administered is at least eighteen (18) years of age but has a
legal guardian, the legal guardian of the individual.
(C) If the individual to whom the immunization is to be
administered is at least eighteen (18) years of age but has no
legal guardian, the individual.
A parent or legal guardian who is required to give consent under
this subdivision must be present at the time of immunization.
(d) If the Indiana department of health or the department of
homeland security determines that an emergency exists, subject to
IC 16-41-9-1.7(a)(2), a pharmacist may administer any immunization
in accordance with:
(1) the requirements of subsection (c)(1) through (c)(3); and
(2) any instructions in the emergency determination.
(e) A pharmacist or pharmacist's designee shall provide
EH 1182—LS 6758/DI 92 22
immunization data to the immunization data registry (IC 16-38-5) in a
manner prescribed by the Indiana department of health unless:
(1) the individual receiving the immunization;
(2) the parent of the individual receiving the immunization, if the
individual receiving the immunization is less than eighteen (18)
years of age; or
(3) the legal guardian of the individual receiving the
immunization, if a legal guardian has been appointed;
has completed and filed with the pharmacist or pharmacist's designee
a written immunization data exemption form, as provided in
IC 16-38-5-2.
(f) If an immunization is administered under a protocol, then the
name, license number, and contact information of the physician who
wrote the protocol must be posted in the location where the
immunization is administered. A copy of the protocol must be available
for inspection by the individual receiving the immunization.
(g) A pharmacist may administer an immunization that is provided
according to a standing order, prescription, or protocol issued under
this section or IC 16-19-4-11 by the state health commissioner or the
commissioner's designated public health authority who is a licensed
prescriber. If a pharmacist has received a protocol to administer an
immunization from a physician and that specific immunization is
covered by a standing order, prescription, or protocol issued by the
state health commissioner or the commissioner's designated public
health authority, the pharmacist must administer the immunization
according to the standing order, prescription, or protocol issued by the
state health commissioner or the commissioner's designated public
health authority.".
Page 3, between lines 39 and 40, begin a new line block indented
and insert:
''Alpha'-Methyl butyryl fentanyl (2-methyl-N-(1-
phenethylpiperidin- 4-yl)-N-phenylbutanamide) (9864)".
Page 4, between lines 30 and 31, begin a new line block indented
and insert:
"2',5'-Dimethoxyfentanyl (N-(1- (2,5-dimethoxyphenethyl)
piperidin-4-yl)- N-phenylpropionamide) (9861)".
Page 4, line 42, delete "fentanyl." and insert ''fentanyl
(N-(1-phenethylpiperidin- 4-yl)- N-phenylfuran- 2-carboxamide)
(9834)
3-Furanyl fentanyl (N-(1-phenethylpiperidin- 4-yl)-
N-phenylfuran- 3- carboxamide) (9860)".
Page 5, between lines 7 and 8, begin a new line block indented and
EH 1182—LS 6758/DI 92 23
insert:
"Isovaleryl fentanyl (3-methyl- N-(1-phenethylpiperidin-4-yl)-
N- phenylbutanamide) (9862)".
Page 5, between lines 10 and 11, begin a new line block indented
and insert:
''Meta-Fluorofentanyl (N-(3- fluorophenyl)- N-
(1-phenethylpiperidin-4-yl) propionamide) (9857)
Meta-Fluoroisobutyryl fentanyl (N-(3-fluorophenyl)- N-
(1-phenethylpiperidin-4-yl) isobutyramide) (9858)".
Page 6, between lines 14 and 15, begin a new line block indented
and insert:
''Ortho-Fluorofuranyl fentanyl (N-(2-fluorophenyl)- N-
(1-phenethylpiperidin-4-yl)furan-2-carboxamide) (9863)".
Page 6, between lines 22 and 23, begin a new line block indented
and insert:
''Para-Methoxyfuranyl fentanyl (N-(4-methoxyphenyl)- N-
(1-phenethylpiperidin-4-yl) furan-2-carboxamide (9859)
Para-Methylcyclopropyl fentanyl (N-(4-methylphenyl)- N-
(1-phenethylpiperidin- 4-yl)cyclopropanecarboxamide)
(9865)".
Page 10, between lines 37 and 38, begin a new line block indented
and insert:
''(51) N-(1-amino- 3,3-dimethyl-1- oxobutan-2-yl)-
1-butyl-1H-indazole-3- carboxamide (other name:
ADB–BUTINACA) (7027).
(52) 4-methyl-1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one (other
names: á-PiHP; alpha-PiHP) (7551).
(53) 2-(methylamino)-1-(3-methylphenyl)propan-1-one (other
names: 3–MMC; 3-methylmethcathinone) (1259).".
Renumber all SECTIONS consecutively.
and when so amended that said bill do pass.
(Reference is to HB 1182 as printed January 18, 2024.)
FREEMAN, Chairperson
Committee Vote: Yeas 8, Nays 0.
EH 1182—LS 6758/DI 92 24
SENATE MOTION
Madam President: I move that Engrossed House Bill 1182 be
amended to read as follows:
Page 3, delete lines 17 through 42.
Delete page 4.
Page 5, delete lines 1 through 24.
Renumber all SECTIONS consecutively.
(Reference is to EHB 1182 as printed February 16, 2024.)
GLICK
EH 1182—LS 6758/DI 92